Loading...
Midatech Pharma plc
MTPH.L•LSE
Healthcare
Biotechnology
£18.00
£17.05(1794.74%)

Midatech Pharma plc (MTPH.L) Cash Flow Analysis
The cash flow statement reveals the Midatech Pharma plc (MTPH.L) liquidity trends, with operating cash flow per share at $0.00, reflecting core business performance. Investing activity changes were N/A, indicating capital expenditures or asset sales, while financing activity shifted by N/A, showing debt or equity movements. Free cash flow per share was $0.00, highlighting funds available for growth or shareholder returns. Year-over-year change in operating cash flow is N/A, demonstrating financial health shifts. For deeper insights, compare these figures with income statements and balance sheets to assess sustainability and strategic priorities.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan